Sept 27 (Reuters) - Cosmo Pharmaceuticals Nv COPN.S :
* COSMO AND GLENMARK ANNOUNCE THE SIGNING OF DISTRIBUTION
AND
LICENSE AGREEMENTS FOR WINLEVI® IN EUROPE AND SOUTH AFRICA
* CASSIOPEA WILL BE RESPONSIBLE FOR CENTRALIZED MARKETING
AUTHORIZATION FOR WINLEVI AT EUROPEAN MEDICINES AGENCY
* GLENMARK WILL UNDERTAKE REGISTRATION OF WINLEVI IN SOUTH
AFRICA
AND IN UK
* COSMO PHARMACEUTICALS - WILL RECEIVE AN UPFRONT PAYMENT
OF USD
5 MILLION, IN ADDITION TO DOUBLE-DIGIT REGULATORY AND SALES
MILESTONES
* WILL RECEIVE DOUBLE-DIGIT ROYALTIES ON NET SALES
Source text for Eikon: ID:nEQ2J5cbja
Further company coverage: COPN.S
((Reuters.Briefs@thomsonreuters.com;;))